Issued Patents All Time
Showing 1–25 of 28 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6117882 | 5-HT.sub.4 agonists and antagonists | John M. Schaus, Dennis C. Thompson | 2000-09-12 |
| 6069152 | 5-HT.sub.4 agonists and antagonists | John M. Schaus, Dennis C. Thompson | 2000-05-30 |
| 5886003 | Methods of treating or ameliorating the symptoms of venomous bites and stings | Kirk Willis Johnson | 1999-03-23 |
| 5880134 | Method for using ergoline compounds to effect physiological and pathological functions at the 5-HT.sub.7 receptor | Daniel J. Cushing | 1999-03-09 |
| 5840747 | Calcium channel antagonists | — | 1998-11-24 |
| 5817676 | Indazolecarboxamides | John T. Catlow, Michael O. Martinelli, John M. Schaus, Steven Swanson, Dennis C. Thompson +1 more | 1998-10-06 |
| 5798367 | Indazolecarboxamides | John T. Catlow, Michael John Martinelli, John M. Schaus, Steven Swanson, Dennis C. Thompson +1 more | 1998-08-25 |
| 5744482 | Serotonin agonist in combination with a tachykinin receptor antagonist in the treatment or prevention of migraine | Kirk Willis Johnson, Lee A. Phebus | 1998-04-28 |
| 5739146 | Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted) ergolines | David W. Robertson | 1998-04-14 |
| 5736544 | Naphthylpiperazinyl compounds useful for treating 5HT.sub.2B receptor mediated conditions | James E. Audia, Jaswant S. Gidda, David L. Nelson | 1998-04-07 |
| 5705519 | Method for treating 5-HT.sub.2B receptor related conditions | James E. Audia, Jaswant S. Gidda, David L. Nelson | 1998-01-06 |
| 5698571 | 5-HT.sub.1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine | James E. Audia, Kirk Willis Johnson, Lee A. Phebus, Theresa Branchek | 1997-12-16 |
| 5688807 | Method for treating 5HT.sub.2B receptor related conditions | James E. Audia, Jaswant S. Gidda, David L. Nelson | 1997-11-18 |
| 5674875 | Method of blocking human 5-hydroxytryptamine-2 receptors | David L. Nelson | 1997-10-07 |
| 5563148 | Specific 5-HT3 antagonists | William B. Lacefield, David W. Robertson | 1996-10-08 |
| 5441961 | Substituted cyclo or bicycloalkylamides of (8.beta.)-6-(substituted) ergolines | David W. Robertson | 1995-08-15 |
| 5442078 | Intermediates for specific 5-HT3 antagonists | William B. Lacefield, David W. Robertson | 1995-08-15 |
| 5364863 | Specific 5-HT.sub.3 antagonists | William B. Lacefield, David W. Robertson | 1994-11-15 |
| 5141944 | N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides | David W. Robertson | 1992-08-25 |
| 5043341 | N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides | David W. Robertson | 1991-08-27 |
| 4921982 | 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT.sub.3 antagonists | William B. Lacefield, David W. Robertson | 1990-05-01 |
| 4914107 | Method for selectively blocking 5-HT.sub.2 receptors | Mark J. Goldberg, Louis Lemberger | 1990-04-03 |
| 4902691 | Heteroalkylamides of (8-.beta.)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT.sub.2 receptors | David W. Robertson | 1990-02-20 |
| 4810710 | 4-hydroxycyclohexyl 1-isopropyl-9,10-dihydro-lysergate for the treatment of migraine | Ray W. Fuller, William L. Garbrecht, Kathleen R. Whitten | 1989-03-07 |
| 4762842 | Selective method for blocking 5HT2 receptors | Ray W. Fuller, William L. Garbrecht, Kathleen R. Whitten | 1988-08-09 |